Why the study?
Does the PerFix EXPOSE kit correlate with the PLT VASP/P2Y12 kit for monitoring VASP phosphorylation in patients treated with clopidogrel?
Does the PerFix EXPOSE kit correlate with the PLT VASP/P2Y12 kit for monitoring VASP phosphorylation in patients treated with clopidogrel?
The PerFix EXPOSE kit can be adapted for platelets to monitor VASP phosphorylation and correlates significantly with the standard PLT VASP/P2Y12 kit.
Answers are grounded in this paper and cite their sources.
May support PerFix EXPOSE as alternative for VASP monitoring in clopidogrel patients; hypothesis-generating, needs outcome validation.
A recently released kit (PerFix EXPOSE) was reported to improve the measurement of the degree of phosphorylation of proteins in leukocytes by flow cytometry. We tested its adaptation for platelets to monitor vasodilator-stimulated phosphoprotein (VASP) phosphorylation, which is the basis of a currently used test for the assessment of the pharmacological response to P2Y12 antagonists (PLT VASP/P2Y12). The PerFix EXPOSE kit was compared to the PLT VASP/P2Y12 kit by using blood samples drawn at 24 h post clopidogrel dose from 19 patients hospitalized for a non-cardio-embolic ischemic stroke and treated with clopidogrel monotherapy for at least five days in an observational study. The platelet PerFix method was based on adaptation of the volume of the sample, the centrifugation speed and the incubation temperature. Poor agreement between prevention by adenosine diphosphate (ADP) of PGE1-induced cAMP-mediated VASP phosphorylation and ADP induced aggregation assessed by Light Transmittance Aggregometry was found. We found a significant correlation between the PLT VASP/P2Y12 kit and the PerFix EXPOSE kit. The PerFix EXPOSE kit may also be helpful to monitor adverse effects of second-generation tyrosine kinase inhibitors on platelets.
No takes yet. Share an insight, caveat, or question.
Mallouk et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: